Etiology-Is-Contested-And-Underdetermined

Issue 101 Edition 2026-04-11 6 min read

General

Sources: 1 • Confidence: Medium • Updated: 2026-04-11 20:27

Key takeaways

There is no agreed-upon cause of misophonia and multiple competing theories are currently discussed.
Misophonia reactions are typically trigger-specific and are not primarily driven by the loudness of the sound.
EEG event-related potential research reports different neural responses to trigger sounds in people with misophonia compared with non-trigger sounds and compared with people without misophonia.
Misophonia is characterized by hypersensitivity to specific trigger sounds that elicits strong negative emotional experience and autonomic arousal.
Misophonia is not included as a distinct disorder in DSM-5.

There is no agreed-upon cause of misophonia and multiple competing theories are currently discussed.
Another proposed explanation is that misophonia is an idiopathic medical condition with unknown mechanism and may be comorbid with psychiatric disorders.
A third proposed explanation is that misophonia is a symptomatic manifestation or byproduct of an underlying psychiatric disorder, and evidence linking it to OCD is limited.
Neural hypotheses for misophonia include hyperconnectivity between auditory cortex and limbic emotional systems and/or hyperactivity of regions such as the anterior insula and amygdala.
One proposed theory is that misophonia can be induced or learned due to early-life anxiety or stress interacting with physiological state.

Misophonia reactions are typically trigger-specific and are not primarily driven by the loudness of the sound.
Misophonia responses can rapidly activate fight-or-flight reactions including anger and urges to escape.
Misophonia reactions can occur almost immediately after a trigger sound, involving rapid emotional and physical responses.

EEG event-related potential research reports different neural responses to trigger sounds in people with misophonia compared with non-trigger sounds and compared with people without misophonia.
fMRI research reports increased activation in the right insula, right anterior cingulate cortex, and right superior temporal cortex in people with misophonia when viewing trigger audiovisual clips versus neutral clips.
One mechanistic description is that trigger audiovisual stimuli in misophonia produce anger and physiological arousal via heightened auditory-cortex and salience-network engagement that assigns meaning to the stimuli.

Misophonia is characterized by hypersensitivity to specific trigger sounds that elicits strong negative emotional experience and autonomic arousal.
Common misophonia triggers include chewing, slurping, breathing, pen clicking, and foot tapping, and triggers can vary widely by individual.

Misophonia is not included as a distinct disorder in DSM-5.
Misophonia is often dismissed by others as not real, including by some clinicians.

Existing misophonia treatment algorithms require validation in large population studies to establish efficacy.

What diagnostic criteria and standardized assessment tools (including outcomes) are reliable enough to distinguish misophonia from other sound intolerance conditions and from general annoyance?
What is the causal mechanism of misophonia (learned/induced, idiopathic medical, psychiatric-symptom-based, or primarily neural-circuit-based), and how can these hypotheses be experimentally separated?
How robust and replicable are the reported EEG ERP differences and fMRI activation patterns across large and diverse cohorts, and can they function as clinically useful biomarkers?
What is the real-world efficacy of TRT, CBT, sound therapy, mindfulness/relaxation, and avoidance/coping strategies under controlled comparisons with standardized follow-up?
Which contextual factors (environmental, interpersonal, audiovisual vs audio-only) most strongly modulate trigger responses, and which mitigations work for which trigger profiles?

Clinical validation gap may create demand for standardized diagnostic criteria, assessment tools, and outcomes to distinguish misophonia from other sound intolerance conditions, potentially benefiting developers of validated scales and structured care pathways.
If EEG ERP and fMRI differences prove robust, biomarker-like measures could support objective stratification and treatment tracking, enabling products or services centered on measurement rather than symptom descriptions alone.
Lack of DSM-5 recognition and legitimacy friction may constrain reimbursement and adoption, shifting activity toward self-pay coping and individualized mitigation approaches rather than standardized covered clinical pathways.

Large, diverse cohort studies replicate reported EEG ERP differences and fMRI activation patterns and show they distinguish trigger responses from general annoyance and related conditions with reliable performance.
Consensus diagnostic criteria and standardized assessment tools emerge and demonstrate reliability and clinical utility across settings, including validated outcomes suitable for controlled comparisons.
Controlled studies with standardized follow-up show real-world efficacy for specific interventions such as TRT, CBT, sound therapy, mindfulness, or structured coping strategies for defined trigger profiles.

Replication attempts in large, diverse cohorts fail to reproduce EEG ERP or fMRI differences, or effects do not distinguish misophonia from other sound intolerance conditions or general annoyance.
Proposed diagnostic criteria and assessment tools show poor reliability, high overlap with other conditions, or inconsistent outcomes that prevent standardization.
Controlled comparisons show no meaningful efficacy for leading treatment approaches versus controls, or benefits do not generalize beyond narrow contexts or specific triggers.